" class="no-js "lang="en-US"> Clinical Trials Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:


Top Post

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients […]

Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS)

Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, today announced it has […]

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa

 Nanoscope Therapeutics, today announced topline results from the Phase 2b multicenter, randomized, double-masked, sham-controlled RESTORE […]

CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment

CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]

NRx Pharmaceuticals to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression

NRx Pharmaceuticals, a clinical-stage CNS biopharmaceutical company, today reported that the independent Data Safety Monitoring […]

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

The United States Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to […]

Novartis Trial Shows Benefit in Patients with Breast Cancer

Novartis today announced positive topline results from an interim analysis of NATALEE, a Phase III […]

PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Needle-free Precision Delivery Systems

PharmaJet, a company engineering precision delivery systems that may overcome the challenges of nucleic acid […]

Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg function, […]

Newron Reports Topline Results From All Patients in Study Evaluating Evenamide as Add-on Therapy for Treatment-Resistant Schizophrenia

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more